Review highlights lack of consistency in FDA’s ‘close call’ approvals
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesBiotechnologyHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy